Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.2K

Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence!

Olivier Mignen1, Jean-Pierre Vannier2, Pascale Schneider2

  • 1LBAI, UMR1227, Univ Brest, Inserm, Brest, France.

Biochemical Pharmacology
|December 1, 2023
PubMed

Insights

Orai1 channel modulators show promise for cancer treatment by targeting calcium entry pathways. These modulators offer potential therapeutic benefits for various cancers, impacting cell proliferation and metastasis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Orai proteins are crucial for calcium entry in non-excitable cells, regulating Store-Operated Calcium Entry (SOCE) and store-independent Calcium Entry (SICE) pathways.
  • Dysregulation of these calcium signaling pathways is linked to increased tumor cell proliferation, migration, metastasis, and angiogenesis.
  • Orai1, a key Orai protein, is recognized as a significant therapeutic target for various diseases.

Purpose of the Study:

  • To review the significance of Orai1 channel modulators as potential therapeutic agents.
  • To highlight the therapeutic value of Orai1 modulators in the context of cancer treatment.
  • To discuss the role of Orai1 in cancer progression and its potential as a drug target.

Main Methods:

  • Literature review of studies on Orai1 function, calcium signaling, and therapeutic applications.
  • Analysis of existing data on Orai1 inhibitors and modulators in preclinical and clinical settings.
  • Synthesis of information regarding the impact of Orai1 on cancer hallmarks.

Main Results:

  • Orai1 channel inhibitors have been investigated in therapeutic trials for conditions like psoriasis and pancreatitis.
  • Emerging evidence indicates that Orai1 channel modulators may possess anti-cancer properties.
  • Targeting Orai1 offers a potential strategy to inhibit tumor growth and metastasis.

Conclusions:

  • Orai1 channel modulators represent a promising class of therapeutic tools.
  • The modulation of Orai1 channels holds significant potential for the development of novel cancer therapies.
  • Further research into Orai1 modulators could lead to effective treatments for various cancers.
Keywords:
CalciumCancerOrai1Orai1 channel modulatorsSOCETherapeutics

More Related Videos

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

728
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K